CP:TSX
Canadian Pacific Kansas City Limited
Data as of 2026-03-10 - not real-time
CA$113.92
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Canadian Pacific Kansas City (CP.TO) is trading at C$113.92, comfortably above its 20‑day SMA of C$116 (just below the 50‑day SMA) and well above the 200‑day SMA, indicating a bullish price structure. The stock is sitting on a technical support around C$108.7 and faces resistance near C$122.3, while volume has been increasing and the 30‑day volatility is roughly 27%, suggesting active market participation. Momentum indicators are mixed – the RSI sits near the midpoint at 51, and the MACD histogram is negative, signaling a short‑term bearish tilt despite an overall bullish trend direction. The market sentiment is in the “Extreme Greed” zone (Fear & Greed Index 75.9), which aligns with the recent 6.8% weekly gain and the recent record grain shipments reported in the news.
Fundamentally, CP delivers strong operating margins (44% operating, 27% net) and a modest revenue growth of 1.3%. Its PE of ~25 is below the industry average of ~30, and the forward PE of ~19 suggests earnings expansion ahead. The dividend yield of ~0.8% with a low payout ratio (~19%) appears sustainable given robust operating cash flow and free cash flow. However, the company carries a sizable debt load (≈C$23.6 bn) and a DCF‑derived fair value of only C$6.5, implying a significant overvaluation gap. Recent news of a US$1.2 bn debt offering underscores the need to monitor leverage, while the record grain volumes highlight operational strength.
Fundamentally, CP delivers strong operating margins (44% operating, 27% net) and a modest revenue growth of 1.3%. Its PE of ~25 is below the industry average of ~30, and the forward PE of ~19 suggests earnings expansion ahead. The dividend yield of ~0.8% with a low payout ratio (~19%) appears sustainable given robust operating cash flow and free cash flow. However, the company carries a sizable debt load (≈C$23.6 bn) and a DCF‑derived fair value of only C$6.5, implying a significant overvaluation gap. Recent news of a US$1.2 bn debt offering underscores the need to monitor leverage, while the record grain volumes highlight operational strength.
Trading Recommendations
Short Term
< 1 yearbuy
Conviction: 7/10
Key Factors
- Price above key moving averages and holding support
- Increasing volume and bullish trend direction
- Technical momentum still near neutral, offering upside
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Strong operating margins and cash flow generation
- Dividend sustainability with low payout ratio
- Upside potential of ~7% versus current price
Long Term
> 3 yearshold
Conviction: 6/10
Key Factors
- High debt level and DCF fair value indicating overvaluation
- Stable core business across Canada, US and Mexico
- Exposure to regulatory and commodity cycle risks
Key Metrics & Analysis
Financial Health
Revenue Growth1.30%
Profit Margin27.46%
P/E Ratio25.0
ROE8.64%
ROA4.39%
Debt/Equity50.40
P/B Ratio2.2
Op. Cash FlowCA$5.3B
Free Cash FlowCA$2.0B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI51.6
SupportCA$108.67
ResistanceCA$122.25
MA 20CA$116.00
MA 50CA$107.16
MA 200CA$105.69
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair ValueCA$6.52
Target PriceCA$121.55
Upside/Downside6.70%
GradeOvervalued
TypeBlend
Dividend Yield0.81%
Risk Assessment
Beta0.66
Volatility27.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.